Financial Trading Blog
European Breakouts: Stocks Near 52-Week Highs
Stocks in Europe are surging towards new records heading into the third quarter of the year, and the ECB potentially becoming less hawkish as inflation eases could give outperforming stocks new wings.
10 European Stocks Near 52-Week Highs: Weekly Performance
- Bayer (BAYN) +26%
- Merck KGaA (MRK) +11%
- Lufthansa (LHA) +9%
- Avolta (AVOL) + 6%
- Nestle (NESN) +6%
- Novartis (NOVN) +6%
- Accor (AC) +5%
- Air Liquide (AI) +4%
- Safran (SAF) +4%
- Anheuser-Busch InBev (ABI) +4%
More Highs for European Stocks?
European stocks have been cautiously optimistic this week, with the Stoxx 50 rising to near record highs as tech and industrials led a surge on Tuesday. Tech stocks were rebounding after last week's selloff that was mostly attributed to profit-taking. The hiccup over the weekend regarding the reopening of the Strait of Hormuz seems to have reassured markets that energy supplies are being restored despite momentary setbacks. Industrials have been under pressure since March due to higher energy input costs and are seeing resurgent interest as crude prices return to pre-war levels. Lower energy costs are expected to ease upward inflationary pressures, making further ECB hikes less likely and allowing more room for economic expansion.
The benchmark Stoxx 600 recorded its largest quarterly gain in five years as stocks recovered from the March lows following the start of the war with Iran. The index has managed three consecutive gains, accumulating almost 10% growth in the quarter. The tech sector was the top performer, even growing faster than its American counterpart, as investors took advantage of lower European valuations. This opens the question of whether the momentum can continue.
Can European Equities Outperform American?
According to JPMorgan and Panmure, the answer is yes, but they point to different reasons. JPMorgan expects earnings to pick up in the second half, while Panmure sees investors turning to Europe for more attractive valuations. Both agree there is broad-based growth potential. A quick look at stocks near 52-week highs, potentially poised for a breakout, shows a diverse range of sectors, implying that European equity gains could be broad-based. Here's what's been driving some of the leading stocks lately:
Bayer Boosted by SCOTUS Ruling
The German chemicals company's outperformance is attributable to the 25 June US Supreme Court ruling that limited its exposure to Roundup litigation. This has been a long-standing overhang for the company since acquiring glyphosate developer Monsanto in 2018. The company has spent over $10 billion to resolve lawsuits around the litigation and currently has set aside $7.5 billion for remaining legal action. The Court's ruling is widely understood to significantly reduce state-level claims, with investors likely to see an adjustment in litigation expenses in the company's next earnings release.
Merk Supported by M&A
German Merck's recent gains come after it announced plans to acquire Bio-Techne (TECH) for $11.3 billion, expanding its presence in the key American market. Merck expects to realise around €140M in synergies from the deal and would see an improvement in its EBITDA margin. Last quarter, Bio-Techne reported sales of $311 million. Management stressed that the deal's value lay in unlocking Bio-Techne's innovation and giving it scale through the German firm's broader geographic presence.
Lufthansa Soars Ahead of Airlines
The German flag carrier has been supported as easing fuel supply conditions improve with the partial reopening of the Strait of Hormuz. Previously, the company had maintained its year-end guidance despite the situation in the Middle East. Overall, European airlines have been buoyed by the shift in the geopolitical situation. However, Lufthansa might see a larger recovery, as it still operates a relatively older fleet that is less fuel-efficient (such as four-engine 747s on trans-Atlantic routes). It has more room to rebound as fuel costs are expected to normalise in the latter half of the year amid broader market growth in European air travel.
It's easy to open an account
- Fill in our simple online application form
- Fund your account
- Start trading the global markets instantly!
SEARCH FOR AN ARTICLE:
Enter a keyword and search for all relevant articlesMARKET ANALYSIS
RECENT POSTS
DISCLAIMER
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 61% of retail investors lose money when trading spread bets and CFDs with this provider. You should consider whether you understand how spread bets and CFDs work and whether you can afford to take the high risk of losing your money. For professional clients, spread betting and CFD trading can also result in losses larger than your initial stake or deposit.
Spreadex Ltd is authorised and regulated by the Financial Conduct Authority, provides an execution only service and does not provide advice in any way. Nothing within this update should be deemed to constitute the provision of investment advice, recommendations, any other professional advice in any way, or a record of our trading prices. This update does not constitute or form part of an offer of, or solicitation for a transaction in any financial instrument, nor shall it or the fact of its distribution form the basis of, or be relied on in connection with, any contract therefore. Any persons placing trades based on their interpretation of the comments or information within this update does so entirely at their own risk.
No representation, warranty, or undertaking, express or limited, is given as to the accuracy or completeness of the information or opinions contained within this update by Spreadex Ltd or any of its employees and no liability is accepted by such persons for the accuracy or completeness of any such information or opinions. As such, no reliance may be placed for any purpose on the information and opinions contained within this update.
The information contained within this update is the intellectual property of Spreadex Ltd and is protected by UK and International copyright laws. All rights reserved. Users may however freely download, distribute and reproduce extracts of the contents, subject always to accrediting Spreadex Ltd as the source and providing a hyperlink to www.spreadex.com.